| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |